Scott E. Guimond

5.3k total citations · 1 hit paper
60 papers, 3.6k citations indexed

About

Scott E. Guimond is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Scott E. Guimond has authored 60 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 47 papers in Cell Biology and 14 papers in Genetics. Recurrent topics in Scott E. Guimond's work include Proteoglycans and glycosaminoglycans research (47 papers), Glycosylation and Glycoproteins Research (23 papers) and Fibroblast Growth Factor Research (23 papers). Scott E. Guimond is often cited by papers focused on Proteoglycans and glycosaminoglycans research (47 papers), Glycosylation and Glycoproteins Research (23 papers) and Fibroblast Growth Factor Research (23 papers). Scott E. Guimond collaborates with scholars based in United Kingdom, Italy and United States. Scott E. Guimond's co-authors include Jeremy E. Turnbull, Soo‐Hyun Kim, Andrew K. Powell, Alan C. Rapraeger, Bradley B. Olwin, Ulf Lindahl, Marco Maccarana, Edwin A. Yates, Mark A. Skidmore and Alison Krufka and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Scott E. Guimond

60 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor

2011 896 citations Jeremy E. Turnbull, Scott E. Guimond et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott E. Guimond United Kingdom	30	2.2k	2.0k	462	402	364	60	3.6k
Shuji Mizumoto Japan	28	1.7k 0.8×	1.7k 0.9×	648 1.4×	393 1.0×	265 0.7×	88	2.9k
Hiroko Habuchi Japan	38	2.6k 1.2×	2.6k 1.3×	569 1.2×	619 1.5×	194 0.5×	66	3.7k
Naoki Itano Japan	38	3.7k 1.7×	3.6k 1.8×	454 1.0×	289 0.7×	374 1.0×	75	6.6k
John Lincecum United States	16	2.5k 1.1×	2.1k 1.0×	429 0.9×	286 0.7×	291 0.8×	16	4.2k
Tadahisa Mikami Japan	28	2.3k 1.1×	2.3k 1.1×	505 1.1×	467 1.2×	120 0.3×	49	3.5k
Denis Barritault France	43	3.2k 1.5×	2.1k 1.0×	599 1.3×	172 0.4×	639 1.8×	193	5.9k
Kirsi Rilla Finland	35	2.6k 1.2×	2.0k 1.0×	274 0.6×	163 0.4×	187 0.5×	90	4.0k
Bertrand Delpech France	37	2.1k 1.0×	2.3k 1.1×	317 0.7×	132 0.3×	197 0.5×	122	4.1k
Marion Kusche‐Gullberg Sweden	35	3.2k 1.5×	3.2k 1.6×	612 1.3×	804 2.0×	218 0.6×	59	4.8k
James H. Kimura United States	38	2.3k 1.0×	2.5k 1.2×	382 0.8×	212 0.5×	689 1.9×	73	5.1k

Countries citing papers authored by Scott E. Guimond

Since Specialization

Citations

This map shows the geographic impact of Scott E. Guimond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Guimond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Guimond more than expected).

Fields of papers citing papers by Scott E. Guimond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. Guimond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Guimond. The network helps show where Scott E. Guimond may publish in the future.

Co-authorship network of co-authors of Scott E. Guimond

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. Guimond. A scholar is included among the top collaborators of Scott E. Guimond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. Guimond. Scott E. Guimond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mycroft‐West, Courtney J., Scott E. Guimond, Patricia Procter, et al.. (2023). A sulphated glycosaminoglycan extract from Placopecten magellanicus inhibits the Alzheimer's disease β-site amyloid precursor protein cleaving enzyme 1 (BACE-1). Carbohydrate Research. 525. 108747–108747. 2 indexed citations

Mycroft‐West, Courtney J., Scott E. Guimond, Patricia Procter, et al.. (2021). Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer’s Disease β Secretase, BACE1. Marine Drugs. 19(4). 203–203. 8 indexed citations

Miller, Rebecca L., Scott E. Guimond, Ralf Schwörer, et al.. (2020). Shotgun ion mobility mass spectrometry sequencing of heparan sulfate saccharides. Nature Communications. 11(1). 1481–1481. 49 indexed citations

Mycroft‐West, Courtney J., Patricia Procter, Scott E. Guimond, et al.. (2019). Tools for the Quality Control of Pharmaceutical Heparin. Medicina. 55(10). 636–636. 6 indexed citations

Mycroft‐West, Courtney J., Patricia Procter, Scott E. Guimond, et al.. (2019). A Glycosaminoglycan Extract from Portunus pelagicus Inhibits BACE1, the β Secretase Implicated in Alzheimer’s Disease. Marine Drugs. 17(5). 293–293. 9 indexed citations

Chanalaris, Anastasios, et al.. (2018). Heparan Sulfate Proteoglycan Synthesis Is Dysregulated in Human Osteoarthritic Cartilage. American Journal Of Pathology. 189(3). 632–647. 35 indexed citations

Skidmore, Mark A., et al.. (2017). A semi-synthetic glycosaminoglycan analogue inhibits and reverses Plasmodium falciparum cytoadherence. PLoS ONE. 12(10). e0186276–e0186276. 11 indexed citations

Guimond, Scott E., et al.. (2016). Dynamic changes in heparan sulfate during muscle differentiation and ageing regulate myoblast cell fate and FGF2 signalling. Matrix Biology. 59. 54–68. 37 indexed citations

Solari, Valeria, Timothy R. Rudd, Scott E. Guimond, et al.. (2015). Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding. Organic & Biomolecular Chemistry. 13(21). 6066–6072. 7 indexed citations

10.

Tyler, Peter C., Scott E. Guimond, Jeremy E. Turnbull, & Olga V. Zubkova. (2015). Single‐Entity Heparan Sulfate Glycomimetic Clusters for Therapeutic Applications. Angewandte Chemie International Edition. 54(9). 2718–2723. 31 indexed citations

11.

Xu, Ruoyan, Alessandro Ori‬‬, Timothy R. Rudd, et al.. (2012). Diversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions. Journal of Biological Chemistry. 287(47). 40061–40073. 64 indexed citations

12.

Skidmore, Mark A., et al.. (2010). Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection. Nature Protocols. 5(12). 1983–1992. 46 indexed citations

13.

Skidmore, Mark A., Scott E. Guimond, Timothy R. Rudd, et al.. (2008). The Activities of Heparan Sulfate and its Analogue Heparin are Dictated by Biosynthesis, Sequence, and Conformation. Connective Tissue Research. 49(3-4). 140–144. 36 indexed citations

14.

Guimond, Scott E., Jeremy E. Turnbull, & Edwin A. Yates. (2006). Engineered Bio‐Active Polysaccharides from Heparin. Macromolecular Bioscience. 6(8). 681–686. 12 indexed citations

15.

Guimond, Scott E. & Jeremy E. Turnbull. (2005). Heparan Sulphate-Growth Factor Interactions in Development and Disease. Trends in Glycoscience and Glycotechnology. 17(98). 241–253. 1 indexed citations

16.

Barbosa, Isabelle, Christophe Morin, Stephanie García, et al.. (2004). A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis. Journal of Cell Science. 118(1). 253–264. 24 indexed citations

17.

Yates, Edwin A., Scott E. Guimond, & Jeremy E. Turnbull. (2003). Highly Diverse Heparan Sulfate Analogue Libraries: Providing Access to Expanded Areas of Sequence Space for Bioactivity Screening. Journal of Medicinal Chemistry. 47(1). 277–280. 34 indexed citations

18.

Ford-Perriss, M., Kirsty Turner, Scott E. Guimond, et al.. (2003). Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development. Developmental Dynamics. 227(2). 170–184. 85 indexed citations

19.

Ford-Perriss, M., Scott E. Guimond, Ursula Greferath, et al.. (2002). Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling. Glycobiology. 12(11). 721–727. 57 indexed citations

20.

Guimond, Scott E., Kirsty Turner, Magdalena Kita, M. Ford-Perriss, & Jeremy E. Turnbull. (2001). Dynamic biosynthesis of heparan sulphate sequences in developing mouse brain: a potential regulatory mechanism during development. Biochemical Society Transactions. 29(2). 177–181. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact